SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-18-107597
Filing Date
2018-04-04
Accepted
2018-04-04 16:51:33
Documents
1
Group Members
SOFTBANK VISION FUND L.P.SVF GP (JERSEY) LTDSVF HOLDINGS (UK) LLP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d563900dsc13da.htm SC 13D/A 84661
  Complete submission text file 0001193125-18-107597.txt   86198
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS (441) 824-8101
Myovant Sciences Ltd. (Subject) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-89732 | Film No.: 18737874
SIC: 2834 Pharmaceutical Preparations

Mailing Address 69 GROSVENOR STREET LONDON X0 W1K3JP
Business Address 69 GROSVENOR STREET LONDON X0 W1K3JP 6508435214
SVF Investments (UK) Ltd (Filed by) CIK: 0001716729 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A